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Abstract In this study we demonstrate that Raji cells, a CR2- 
positive Burkitt lymphoma-derived cell line, during cell growth, 
need the cross-linking of multiple OKB7 binding sites or C3d 
determinants to mediate signal transduction. The loss of one of 
these affects the cellular response. Moreover, OKB7, the anti- 
CR2 MoAb, recognizes C3d determinants on the cell surface and 
inhibits signal transduetion induced by anti-C3d polyclonal anti- 
body. Since Raji ceils are always CR2 positive during cell growth, 
we suppose that at least another protein, along with CR2, may 
be involved in setting up a cell surface complex able to receive 
and transduce the signal triggered by OKB7. In our experimental 
system the protein that offers a third binding site to OKB7, may 
be represented by a 33 kDa protein bearing C3d determinants. 
Key words': Complement receptor type 2; Anti-CR2 MoAb; 
Polyclonal antibodies for C3c and C3d fragments of human 
complement (C3); lnositol-(1,4,5)trisphosphate; Anti-C3d 
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1. Introduction 
Human hepatocytes, monocytes, epithelial and endothelial 
cells synthesize C3 [1]. This seems to be true also for Raji cells, 
a CR2 positive Burkitt lymphoma derived cell line, which pro- 
duce a 5.2-kb message and a truncated message of approxi- 
mately 1.8-kb in size (W. Lernhardt, personal communication, 
[1]). Northern blot analysis revealed that the truncated message 
corresponds to the C3 c~ chain, and it is probably analogous to 
the truncated C3 message produced by murine T-cell hybrid- 
oma, lymphoma nd macrophage cell lines [2]. Therefore, Raji 
cells seem to be able to produce C3 and use it. It has been 
already reported that hydrolyzed C3 (C3n2o) can be cleaved by 
cell surface proteins [3], and the derived C3 fragments can 
substain cell growth [3,4]. The cleavage of C3H2 o or iC3b is 
mediated by the cofactor activity that Complement Receptor 
type 2 (CR2) fulfils on the surface of CR2 positive cells [3,5]. 
CR2, a 140-145 kDa membrane protein, is the C3d receptor 
[6]. It also acts as a cellular receptor for Epstein-Barr virus 
(EBV) [7,8] and interferon c~ (c~-IFN) [9]. It can be phosphor- 
ylated following interaction with its ligands [10,11] and it is 
involved in important immunoregulatory processes, including 
*Corresponding author. Fax: (39) (6) 44230229. 
Abbreviations. CR2, Complement receptor type 2; OKB7, Anti-CR2 
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activation and growth of B lymphoblastoid cells [12 16]. CR2 
has also been found associated with other cell surface proteins 
in mediating multiple signals [11,17 19]. Moreover, CR2 posi- 
tive cells bind hemolytic inactive C3 and its fragments C3b, 
iC3b, C3dg and C3d [20-26]. 
Recently, the C3d homologous regions described on different 
CR2 ligands (~-IFN, EBV) [9,27,28] have been considered in 
the CR2 function. However, little is known about the expres- 
sion of anti-C3d reactive binding sites (hereafter eferred as 
C3d determinants) onCR2 or on proteins of CR2 positive cells, 
even if it is demonstrated that anti-C3D antibody inhibits the 
binding of c~-IFN to CR2 [9]. 
We used CR2 positive Raji cells to investigate whether they 
could express C3d determinants. We found that: (a) Raji cells 
can be C3d positive; (b) cross-linking of multiple C3d determi- 
nants by anti-C3d polyclonal antibody mediates an increase of 
inositol-(l,4,5)trisphosphate (InsP3), and (c) OKB7, an anti- 
CR2 MoAb that has been already reported to cross-link two 
CR2 epitopes [29], to stimulate B cell activation [30] and to 
mobilize intracellular C 2+ in CR2 positive T cells [31], mediates 
signal transduction by InsP 3 and inhibits InsP 3 release induced 
by anti-C3d. Furthermore, we found that OKB7 recognizes 
also a 33 kDa protein bearing C3d determinants. 
2. Materials and methods 
2.1. Experimental procedures 
Raji cells were cultured in RPMI-1640 (Flow Lab. Ltd., lrvine, 
Ayrshire, Scotland) supplemented with 10% heat inactivated fetal calf 
serum (FCS) (Flow). Human serum, obtained from a healthy donor, 
was stored at -20°C and thawed before use. C3d [32] was kindly 
supplied by Prof. J.D. Lambris, University of Pennsylvania, Philadel- 
phia, PA, USA. The presence of C3 fragments on the cell surface was 
analyzed by flow cytometry using fluorescein isothiocyanate (FITC)- 
conjugated rabbit anti-human C3d (17/lg/ml) or anti-human C3c (34 
,ug/ml) polyclonal antibodies (Dakopatts, Copenhagen, Denmark). In 
some experiments the fate of CR2 was monitorized by phycoerythrin 
(PE)-conjugated mouse anti-CR2 MoAb (OKB7-PE) (5 ,ug/ml) (Ortho 
Pharmaceutical Corp., Raritan, N J, USA). Reactivity with mouse IgG- 
PE (Ortho) served as negative control. The samples were analyzed in 
FACScan (Beckton Dickinson, Mountain View, CA, USA). 
2.2. InsP~ mass assay 
Raji cells were collected few seconds alter seeding in complete me- 
dium (t = 0), or after 5 h (t = 5), 18 h (t = 18) and 24 h (t = 24). The 
washed cells were resuspended in ice-cold phosphate buffered saline 
(PBS) at the concentration f I × 10 v cells/ml and aliquots of 0.1 ml were 
incubated for 1 min or 20 min at 4°C with PBS, anti-C3c polyclonal 
antibody (6 ,ug/ml), anti-C3d polyclonal antibody (1.7 ,ug/ml), anti- 
mouse IgG (5/Jg/ml) or OKB7 (5 ~g/ml). For some experiments, Raji 
cells were incubated for 30 min at 4°C with OKB7. The washed cells 
(OKB7-coated) were treated for 1 min at 4°C with PBS, anti-C3c, 
anti-C3d or anti-mouse lgG. Treatments were stopped by adding 30,ul 
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of cold perchloric acid (20%, v/v) (PCA). The samples were transferred 
on ice for 30 rain. Acid extracts were centrifuged and supernatants were 
neutralized with 5 M KOH, 0.7 M HEPES and 10 mM EDTA. The 
precipitated salts were removed by centrifugation a d InsP3 content in 
the cellular extracts was determined by a specific radioreceptor assay, 
TRK 1000 (Amersham, Buckinghamshire, UK). 
2.3. NaDodSO4/polyacrylamide gel lectrophoresis (SDS-PAGE) and 
Western blot analysis 
2 × 106 cells were washed and treated for 30 rain at 37°C with PBS, 
OKB7 (5/.tg/ml), HB5 (5 ,ug/ml) or anti-HLA-DR (5/~g/ml) (Beckton 
Dickinson). The pellets were stored for 10 days at -80°C. 0.1 ml of cell 
culture supernatants were collected after three days, lyophilised and 
stored for 10 days at -80°C. The thawed samples were dissolved in 30 
,ul of Laemmli's buffer [33], sonicated (Soni Prep) and boiled for 3 min, 
before loading the SDS-PAGE. For each run prestained standard pro- 
teins (Bio-Rad, Richmond, CA, USA) were included. Proteins were 
transferred onto nitro-cellulose trips (120 min at 75 V) and incubated 
overnight at 4°C with PBS/non-fat milk (5%, w/v). The strips were then 
incubated with anti-C3d polyclonal antibody (l:500, PBS-BSA 1%) 
(Dako), anti-C3c MoAb (1:150, PBS-BSA 1%) or anti-C3d MoAb 
( 1 : 300, PBS-BSA 1%) (Quidel, San Diego, CA, USA) for 90 min at room 
temperature. Afterwards, the strips were incubated with the respective 
second antibody (Sigma, Chemical Co, St. Louis, MO, USA) (1 : 1000, 
PBS/BSA 1%) for 60 min at room temperature. Proteins were visualized 
by the ECL prcedure (Amersham). 
2.4. lmmunoprecipitation by MoAb or polyclonal anti-C3d of 
35 [ S]Met-labeledsecretedproteins 
[35S]Met-labeled cells were washed three times with PBS and treated 
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Fig. I. Recognition of C3d determinants byOKB7 or monomenc C3d. 
(A) Raji cells were incubated with PBS (a,b) or OKB7 (c) for 30 rain 
at 4°C. The washed cells were further incubated with rabbit IgG-F1TC 
(a) or anti-C3d°FITC (b,c) for 30 min at 4°C and then analyzed in 
FACScan. (B) Raji cells were incubated for 30 min at 37°C with PBS 
(a,b) or with 0.05/tg of monomeric C3d (c). The washed cells were 
incubated for 30 min at 4°C with rabbit IgG-FITC (a) or anti-C3d- 
FITC (b,c) and analyzed in FACScan. The percent of positive cells is 
reported in each panel. 
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Fig. 2. Increase of InsP3 levels in Raji cells following cross-linking of 
CR2 epitopes or C3d determinants. Raji cells, collected 72 h after 
seeding, were incubated with PBS, anti-C3c polyclonal antibody, anti- 
C3d polyclonal antibody or OKB7 for 1 min (open bars) or 20 min 
(black bars). The incubation was stopped adding cold PCA and the 
InsP 3 content determined by radioimmunoassay. The results derived 
from one representative experiment performed in triplicate. Data were 
reported as mean + S.D. 
for 30 rain at 37°C with PBS, OKB7 (5 flg/ml) or HB5 (5/.tg/ml). The 
supernatants were diluted with RIPA (10 mM Tris, 1 mM EDTA, 50 
mM NaC1, 10 mM KCI, 0.05% Tween 20, 0.1% SDS) (1 : 1 v/v), contain- 
ing 1 mM PMSF (Sigma), aprotinin (10 mg/ml) (Sigma), and leupeptin 
(10 mg/ml) (Sigma). Anti-C3d MoAb (40/tg) (Quidel), anti-C3d poly- 
clonal antibody (40/~g) (Dako) or mouse IgG (40/~g) (Sigma) were 
respectively adsorbed to 30 /zl of Protein-A-Sepharose (20%, w/v) 
(Pharmacia Fine Chemicals, Uppsala, Sweden) for 3 h at 4°C. The 
[35S]Met-labeled supernatants were subsequently incubated for 16 h at 
4°C with packed IgG-Protein-A-Sepharose. The immunocomplexes 
were washed with RIPA, sonicated, boiled for 3 min and separated by 
SDS-PAGE. 
3.  Resu l ts  
3.1. Recognition of C3d determinants by OKB7 or monomeric 
C3d 
Raji cells could express C3d determinants. This expression 
was related to still unclear events, however, C3d positive Raji 
cells (Fig. l b, panel A) might become C3d negative following 
preincubation with OKB7 (Fig. lc, panel A). 
C3d positive Raji cells (Fig. lb, panel B) incubated with 0.05 
/lg of monomeric C3d had an unexpected ecrease in the total 
amount of  C3d detectable on the cell surface (Fig. lc, panel B). 
At higher concentrations of the ligand, the binding of mono- 
meric C3d to Raji cells was dose-dependent (data not shown). 
3.2. Increase oJInsP3 levels in Raft cells after cross-linking of 
CR2 epitopes or C3d determinants 
Raji cells treated with PBS or anti-C3c polyclonal antibody 
for 1 min (Fig. 2, open bars) or 20 min (Fig. 2, black bars) 
showed low levels of InsP 3. The InsP3 levels increased following 
cell treatment with OKB7 or anti-C3d for 1 min (Fig. 2, open 
bars), while they dropped to basal levels after 20 min (Fig. 2, 
black bars). These data indicated that the increase of InsP3 
depended on cross-linking of multiple CR2 epitopes or C3d 
determinants during the early events of  cell ligand interaction. 
However, a direct correlation between the presence of C3d 
determinants on the cell surface and their involvement in signal 
transduction was not observed. This because C3d determinants 
could be expressed to a very low extent on the cell surface or 
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~hat he transduction of the signal could involve the disclosing 
f f  hidden C3d determinants. 
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Fig. 3. Modulation of lnsP 3 mediated signals during cell growth. Raji 
cells were collected at t = 0 (panel A), t = 5 h (panel B), t = 18 h (panel 
C) or t = 72 h (panel D) after seeding. The washed cells were incubated 
for 1 rain with PBS, anti-C3c polyclonal antibody, anti-mouse IgG, 
anti-C3d polyclonal antibody, or OKB7 (open bars). OKB7-coated 
cells were incubated for the same period of time with PBS, anti-C3c 
polyclonal antibody, anti-mouse lgG or anti-C3d polyclonal antibody 
(black bars). The incubation was stopped adding cold PCA and the 
InsP3 content determined by radioimmunoassay. The results derived 
from one representative experiment performed in triplicate. Data were 
reported as mean + S.D. 
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Fig. 4. Fate of OKB7-PE bound to CR2. Raji cells were incubated with 
PBS (A1), mouse IgG-PE (A2) or OKB7-PE (5/2g/ml) (B1 B4, C1-C4) 
for 30 min at 37°C. The washed cells were incubated with PBS at 37°C 
and after 0.5 h (BI,C1), 2 h (B2,C2), 8 h (B3,C3) or 24 h (B4,C4) 
aliquots were washed and incubated for further 30 rain at 4°C with PBS 
(B1-B4), or anti-mouse IgG (CI C4). The cells were then analyzed in 
FACScan. The percent of positive cells is reported in each panel. 
3.4. Modulation of InsP3 mediated signals during cell growth 
Raji cells collected at t -- 0 or 18 h of culture were unrespon- 
sive to the inductive signals triggered by anti-C3d or OKB7 
(Fig. 3, panels A, C, open bars). 
Cells collected at t = 5 or 72 h and treated with anti-C3d or 
OKB7 showed increased levels of InsP3 when compared to PBS, 
anti-C3c or anti-mouse lgG treated cells (Fig. 3, panels B, D, 
open bars). 
Similar experiments were performed with OKB7-coated cells 
(Fig. 4, black bars). Raji cells collected at t = 0 or 5 h and 
coated with OKB7 were responsive to inductive signals if the 
OKB7-coated binding sites were cross-linked by anti-mouse 
lgG (Fig. 3, panels A, B, black bars), whereas those collected 
at 18 h were unresponsive (Fig. 4, panel C, black bar). More- 
over, the inductive signal mediated by anti-C3d polyclonal anti- 
body was inhibited by cell pretreatment with OKB7 (Fig. 3, 
panels A, B, C black bars). 
Cells collected at 72 h showed an increase of basal InsP3 (Fig. 
3, panel D). Cell pretreatment with OKB7 could increase the 
expression of C3c and C3d determinants, whose cross-linking 
enhanced InsP3 levels (Fig. 3, panel D, black bars). 
3.5. Fate of the OKB7-PE bound to CR2 
Raji cells incubated with OKB7-PE retained this antibody 
for 24 h (Fig. 4, B1 B4). The cross-linking of the OKBT-PE 
binding sites with anti-mouse IgG, performed at 0.5, 2, or 8 h 
did not remove OKB7-PE from the cell surface (Fig. 4, C1-C3), 
while this happened at 24 h (Fig. 4, C4). Therefore, the Fc 
region of anti-mouse IgG could bind a third binding site, lately 
expressed on OKB7-PE coated-cells, and contribute to the in- 
ternalization or shedding of the bound Ab to CR2. 
3.6. Interaction of'anti-CR2 MoAbs with a 33 kDa protein 
bearing C3d determinants 
Immunoblotting of cellular lysates developed with anti-C3d 
polyclonal antibody showed four bands of 200, 97, 35 and 33 
kDa (Fig. 5, lane b). OKB7 or HB5, two anti-CR2 MoAbs, 
interacted with the 33 kDa band, since the latter was absent in 
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Fig. 5. Interaction of anti-CR2 MoAbs with a 33 kDa protein bearing 
C3d determinants. Raji cells were cultured in complete medium for 
three days, washed and treated for 30 min at 37°C with PBS (b), OKB7 
(c), anti-HLA-DR (d) or HB5 (e). The cellular lysates were run on 9% 
SDS-PAGE, transferred onto nitro cellulose strips and developed by 
anti-C3d polyclonal ntibody. 20/tl of human serum (1:500) (lane a). 
the SDS-PAGE of Raji cells pretreated with these Abs (Fig. 5, 
lanes c, e). MoAb anti-HLA-DR did not interact with the 33 
kDa protein (Fig. 5, lane d). 
3. 7. Secretion of a C3-like protein by Raft cells 
Immunoblotting of three days-culture cell-derived superna- 
tants showed some high molecular weight proteins and a 200 
kDa protein recognized by anti-C3d and anti-C3c MoAbs (Fig. 
6, lanes a, h). Anti-C3d also recognized a 145 kDa protein (Fig. 
6, lane a), whereas anti-C3c recognized another protein with the 
molecular weight of 110 kDa (Fig. 6, lane h). Both MoAbs 
recognized C3 in human serum (Fig. 6, lanes d, e), and both 
cross-reacted with a low molecular weight protein of the com- 
plete medium (Fig. 6, lanes c, f), whereas they did not react with 
RPMI-1640 (Fig. 6, lanes b, g). 
Since the 200 kDa protein was recognized by both anti-C3c 
and anti-C3d MoAbs and co-migrated with C3 of the human 
serum, we refer it as C3-1ike protein. 
3.8. Immunoprecipitation f [35 S] Met-labeled secreted Raft 
proteins by MoAb and polyclonal anti-C3d 
[35S]Met-labeled Raji cells were incubated for 30 rain at 37°C 
with PBS. The relative supernatant, immunoprecipitated with 
anti-C3d MoAb, showed two bands of 97 and 78 kDa (Fig. 7, 
panel A, lane a) which were not precipitated by mouse IgG (Fig. 
7, panel A, lane b). For other experiments, [35S]Met-labeled 
Raji cells were washed and then incubated with PBS, OKB7 or 
HB5. The relative supernatants, immunoprecipitated with anti- 
C3d polyclonal antibody, revealed two bands of 48 and 46 kDa 
(Fig. 7, panel B, lanes c, f, i), These bands were not detectable 
in the whole supernatants (Fig. 7, panel B, lanes a, d, g), sug- 
gesting that they could derive from the cleavage of parental 
proteins with molecular weights higher than 48 and 46 kDa. 
Moreover, these data indicated that the anti-C3d antibodies 
could recognize multiple and different binding sites on the 
parental protein(s), as they immunoprecipitated couples of pro- 
teins of different molecular weights (97/78 kDa or 48/46 kDa). 
4. Discussion 
In this study we demonstrate hat the cross-linking of C3d 
determinants on Raji cells surface with anti-C3d polyclonal 
antibody mediates ignal transduction. Moreover, at least one 
C3d determinant is involved in signal transduction by OKB7, 
as this Ab can recognize C3d determinants on the cell surface. 
The C3d positivity might depend on the binding to the cell 
surface of the secreted C3-1ike protein or on the disclosing of 
the C3d homologous region of CR2 (it is known that twenty 
amino acids in CR224~ 266 share a 23.8 percent homology with 
those in the C3d region of C312°~ 22o and the homology reaches 
80 percent if it is restricted to the first five). The resulting 
coating of Raft cells could be requested for the neutralization 
of high reactive binding sites, while the resulting stripping could 
disclose binding site involved in signal transduction mecha- 
nisms. 
OKB7, as the anti-C3d polyclonal antibody, mediated signal 
transduction in cells collected only at 5 or 72 h; no signal 
transduction was mediated at t = 0 or 18 h. Since Raji cells are 
always CR2 positive during cell growth, we conclude that at 
least another protein, along with CR2, should be involved in 
setting up a cell surface complex able to receive and transduce 
the signal triggered by OKB7. This protein might expose spe- 
cific C3d determinants, which could be internalized/neutralized 
or shedded following interaction with OKB7 or monomeric 
C3d. 
Monomeric C3d, unlikely from its multimeric form, has an 
inhibitory effect on the cellular activation [12]. Therefore, in- 
ductive signals via CR2 should need the involvement of multi- 
ple, at least three, binding sites. The loss of one of them would 
fail cellular response [12,14,27,34] and consequently signal 
transduction. We support his hypothesis as: a) three binding 
sites for native C3-derived proteins, bearing C3d determinants, 
are expressed on Raji cells surface [26], and b) the cross-linking 
of three binding sites by a C3 synthetic peptide, C31187 t214 
produces timulatory effect, whereas other peptides, able to 
bind two binding sites, are uneffective [35]. 
In our experimental system, two binding sites are offered by 
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Fig. 6. Secretion of a C3-1ike protein by Raji cells. 0.1 ml of three 
days-culture Raji cells supernatant (lanes a, h), 0.1 ml of RPMI-1640 
(lanes b, g), 0.1 ml of complete medium (lanes c, f) or 20/.tl of human 
serum (1:500) (lanes d, e) were lyophilised, resuspended in Laemmli's 
buffer, run on 7.5% SDS-PAGE, transferred onto nitro cellulose strips 
and developed by anti-C3d (lanes a-d) or anti-C3c (lanes e-h) MoAbs. 
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Fig. 7. lmmunoprecipitation of [~SS]Met-labeled s creted Raji proteins 
by anti-C3d antibodies. Panel A: [35S]Met-labeled s creted Raji proteins 
were incubated with anti-C3d MoAb (a) or mouse IgG (b), previously 
adsorbed to Protein-A-Sepharose. The immunocomplexes w re washed 
and run on 7.5% SDS-PAGE. Panel B: [35S]Met-labeled Raji ceils were 
treated for 30 min at 37°C with PBS (a), OKB7 (d) or HB5 (g), Aliquots 
of the relative supernatants a  such (a, d, g), treated with Protein-A- 
Sepharose (b, e, h) or immunoprecipitated with anti-C3d polyclonal 
antibody complexed to Protein-A-Sepharose (c,f,i), were run on 9% 
SDS-PAGE. The dry gels were developed by autoradiography. 
CR2 [29], and the third might come from the 33 kDa protein 
recognized by OKB7. The 33 kDa protein was not secreted by 
Raji cells, since it was not immunoprecipitated from [35S]Met- 
labeled supernatants by anti-C3d monoclonal or polyclonal 
antibodies. This protein is supposed to link CR2, through its 
own C3d determinants, to other molecules generating a high 
molecular weight complex. The consequential bindings to this 
complex, of repeated C3d/C3dg molecules or C3d homologous 
regions present on the surface of multimeric CR2 ligands [11- 
14, 27, 28, 34], should mediate signal transduction and the 
physical association of CR2, or part of it, to other cell surface 
proteins [11,17-19]. 
Other proteins expressed in Raji lysates and bearing C3d 
determinants had different behaviours. The 97 and 35 kDa 
proteins were not affected from cell ligand interaction, whereas 
the C3-1ike protein was secreted and cleavable. 
The anti-C3d polyclonal antibody immunoprecipitated, from 
[35S]Met-labeled supernatants, a couple of 48 and 46 kDa bands 
which were absent in the controls. The parental proteins hould 
correspond to the C3-1ike protein or to the high molecular 
weight proteins ecreted by Raji cells and recognized by mono- 
clonal and polyclonal anti-C3d. This protein(s) could interact, 
during its secretion, with the above mentioned cell surface com- 
plex and affect the cellular response to the inductive signals 
mediated by the two Abs. 
During the late events of cell-ligand interaction, the cross- 
linking of OKB7 coated binding sites by anti-mouse IgG ex- 
pressed an increase of lnsP3 similar to that induced by surface 
immunoglobulins in B lymphocytes [36]. This cross-linking, in 
specific conditions, induced the removal of OKB7-PE from the 
cell surface, as emphasized by our cytofluorimetry. Therefore, 
when the Fc region of anti mouse IgG bound a third binding 
site on the cell surface, the OKB7-PE was forced in a new 
conformational state and internalized or shedded following 
breakdown of CR2. This mechanism of action is consistent with 
previous data showing that: CR2 ligands may be internalized 
during the late events of cell-ligand interaction [28]; tumor cells 
undergo shedding [37]; CR2 is a clevable protein [38]; CR2 
fragments are shedded by Raji cells [3941]. 
In conclusion our data support he idea that signal transduc- 
tion via CR2 needs the cross-linking of multiple, at least three, 
binding sites during both the early and late events of cell-ligand 
interaction. 
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